NTLA: Intellia Therapeutics Inc

NTLA新闻

• Benzinga 17:59 Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst - Eli Lilly (NYSE:LLY), Verve Therapeutics (NASDAQ:VERV)
• Investor's Business Daily 13:14 Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover
• Investing 08:56 Intellia’s three-year HAE treatment data shows durability, Citizens JMP says
• Investing 11:27 Intellia’s HAE gene therapy shows 98% attack reduction in three-year data
• Investing 14:56 Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema (HAE) at the European Academy of Allergy and Clini
• Investing 20:12 Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
• Investing 11:51 Canaccord Genuity lowers Intellia stock price target to $54
• Investing 00:06 Cathie Wood’s ARK buys Intellia, 10x Genomics, sells Tesla stock
• Investing 00:02 Cathie Wood’s ARK buys CRISPR, sells Adaptive Biotech stock
• Seeking Alpha 18:25 Intellia: Heart Disease Safety Setback Triggers Selloff - Caution Advised (NASDAQ:NTLA)
• Investing 18:03 Salesforce, Nvidia Lead Market Cap Stock Movers on Thursday
• Benzinga 15:25 Intellia Therapeutics' Rare Heart Disease Candidate Reports Liver Enzyme Spike In Phase 3 Trial, But Stays On Course - Intellia Therapeutics (NASDAQ:NTLA)
• Investing 14:31 Nvidia, Veeva Surge Among Thursday’s Market Cap Stock Movers
• Investing 12:37 Intellia stock holds $45 target despite AE concerns
• Benzinga 12:33 HP Posts Downbeat Earnings, Joins SentinelOne, Best Buy And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Brooge Energy (NASDAQ:BROG), Best Buy Co (NYSE:BBY)
• Investing 11:54 Cantor maintains Intellia stock at $65 target despite trial concern
• Investing 11:48 H.C. Wainwright maintains $30 target on Intellia stock post-safety update
• Investing 11:48 Intellia stock tumbles on safety concerns
• Investing 10:22 BofA cuts Intellia stock target to $39, maintains Buy rating
• Benzinga 09:44 Why Nvidia Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - C3.ai (NYSE:AI), Actelis Networks (NASDAQ:ASNS)
• Investing 08:57 Intellia stock holds after JMP reiterates market perform
• Investing 20:53 Intellia reports progress in Phase 3 clinical trials
• Investing 11:36 Intellia Announces Positive Two-Year Follow-Up Data from Ongoing Phase 1 Study of Nexiguran Ziclumeran (nex-z), in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy at Peri
• Investing 00:02 Cathie Wood’s ARK Buys Intellia, Nextdoor, Sells Block Stock